3

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: July 24, 2014
Period of Report: July 24, 2014
Accession Number: 0001144204-14-044717

View Document ↗ View on SEC.gov ↗